Debate Over Alzheimer's Drug Efficacy and Public Funding

Recent reports highlight conflicting research findings on the meaningful difference made by Alzheimer's drugs, leading to cautious optimism amidst skepticism. Concurrently, decisions are being made to halt public funding for a drug aimed at slowing the disease's progression.

16 Apr, 13:13 — 16 Apr, 13:13

Post Share

Sources

Showing 1 of 2 sources

the-journal3h ago

‘Cautious optimism’ despite research claiming Alzheimer’s drugs ‘make no meaningful difference’

A University of Galway professor said one of the most important things to note is that many of the drugs discussed in the review were never approved.

Read full article →

Coverage Timeline

First report: la-vanguardia · 16 Apr, 04:00|Full coverage: 2 · 9h|Window: 9h

la-vanguardia16 Apr, 04:00First to report

Freno a la financiación pública del fármaco que frena la progresión del alzheimer

9h later

the-journal16 Apr, 13:13Latest update

PERSPECTA

PERSPECTA

Debate Over Alzheimer's Drug Efficacy and Public Funding

Sources

‘Cautious optimism’ despite research claiming Alzheimer’s drugs ‘make no meaningful difference’

Coverage Timeline

Freno a la financiación pública del fármaco que frena la progresión del alzheimer

‘Cautious optimism’ despite research claiming Alzheimer’s drugs ‘make no meaningful difference’

Related Stories

'Astronauts back on Earth': Artemis II crew splashes down after record-breaking moon flyby – video

Researchers Discover Method to Slow Human Aging

Penn & Teller Warn Supreme Court Against 'Junk Science'

Rescue Attempt Underway for Humpback Whale Stranded in German Baltic Sea

PERSPECTA